Benitec Biopharma Inc.BNTCNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank23
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-18.74M
↓ 46% vs avg
Percentile
P23
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-12.81M
Historical baseline
PeriodValueYoY Change
TTM$-18.74M+20.5%
2025$-23.59M-21.6%
2024$-19.40M-7.7%
2023$-18.01M-13.3%
2022$-15.90M-23.9%
2021$-12.83M-70.3%
2020$-7.54M-257.3%
2019$4.79M+156.0%
2018$-8.55M-3.0%
2017$-8.30M-